The prevalence of PD-L1 expression in NSCLC ranges from 24% to 60%, even with a cut-off for positivity set at 5% [14]. In the present study, PD-L1 positivity was seen in 20.4% (10 cases) of NSCLC cases. The gene discussed is CD274; the disease is non-small cell lung carcinoma.